id
stringlengths
1
5
question_id
stringlengths
1
5
document_id
stringlengths
5
7
question
stringlengths
55
970
type
stringclasses
1 value
choices
list
context
stringlengths
0
971
answer
sequence
100
109
2871176
Compared to Placebo plus glimepiride what was the result of Rosiglitazone plus glimepiride on HbA1c level at 26 weeks?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.
[ "significantly decreased" ]
101
146
2871176
Compared to Rosiglitazone plus glimepiride what was the result of Liraglutide (all doses) plus glimepiride on Decreases in diastolic blood pressure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.
[ "no significant difference" ]
102
205
4106715
Compared to placebo what was the result of low Ab group on Prolonged abstinence from smoking rates to 12 months?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
3'AmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14–6.37).
[ "no significant difference" ]
103
93
2944158
Compared to staff inclination replacement what was the result of routine replacement on infiltration?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
For individual IVD dwell times, the clinically indicated group devices had a median dwell time of 85 hours (quartiles 51 and 121 hours), and those replaced routinely had a median dwell time of 71 hours (quartiles 48 and 90 hours) (P < 0.001).
[ "no significant difference" ]
104
192
1852268
Compared to Intravenous piperacillin–tazobactam, 3.375 g every 6 hours what was the result of Inravenous ertapenem, 1 g once a day on obstetric/postpartum infection or gynecologic/postoperative infection?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At the primary efficacy endpoint 2–4 weeks post therapy, 93.9% of patients who received ertapenem and 91.5% of those who received piperacillin–tazobactam were cured (95% confidence interval for the difference, adjusting for strata, –4% to 8.8%), indicating that cure rates for both treatment groups were equivalent.
[ "no significant difference" ]
105
110
2871176
Compared to Placebo plus glimepiride what was the result of Liraglutide (1.2 mg) plus glimepiride on Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5%?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.
[ "significantly increased" ]
106
100
2871176
Compared to Rosiglitazone plus glimepiride what was the result of Liraglutide (1.2 mg) plus glimepiride on HbA1c level at 26 weeks?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.
[ "significantly decreased" ]
107
204
4106715
Compared to placebo what was the result of high Ab group on Prolonged abstinence from smoking rates to 12 months?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
3'AmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14–6.37).
[ "significantly increased" ]
108
138
2871176
Compared to Placebo plus glimepiride what was the result of Liraglutide (1.8 mg) plus glimepiride on HOMA-B?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.
[ "no significant difference" ]
109
199
3187863
Compared to Normal unit & Special unit what was the result of Midwife-led unit on Neonatal outcomes were evaluated by Apgar score <7 at 5 minutes, metabolic acidosis and transfer to NICU within 2 hours of birth?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Of all women randomised to the MU, 15.8% had an epidural, which is a significantly lower rate than 23.3% in the NU (RR 1.47, 95% CI 1.11–1.96) and 24.8% in the SU (RR 1.57, 95% CI 1.16–2.13).
[ "no significant difference" ]
110
119
2871176
Compared to Placebo plus glimepiride what was the result of Liraglutide (1.2 mg) plus glimepiride on ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.
[ "significantly increased" ]
111
400
2690844
Compared to Midline incision what was the result of Transverse incision on Complications after surgery?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "no significant difference" ]
112
472
2847809
Compared to Placebo what was the result of Clopidogrel on Complications and mortality?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03).
[ "no significant difference" ]
113
344
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Time to first COPD exacerbation?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
114
474
2847809
Compared to Placebo what was the result of Clopidogrel on The primary arteriovenous fistula failures at two months?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03).
[ "significantly decreased" ]
115
315
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on 1-hour post-dose FEV1 improvements?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
116
480
2447617
Compared to placebo what was the result of progesterone on The analysis using the dichotomization of GOS scores at 6 months post injury?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048).
[ "significantly increased" ]
117
324
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Mean FEV1 at 12 hours at end of treatment?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
118
406
2690844
Compared to Midline incision what was the result of Transverse incision on Scar width?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "significantly decreased" ]
119
481
2899760
Compared to anterior cervical decompression and fusion (ACDF) with Trabecular MetalTM (TM) what was the result of raditional Smith–Robinson (SR) procedure with autograft on Fusion rate?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
usion rate in the SR group was 92%, and in the TM group 69% (P < 0.05).
[ "significantly increased" ]
120
224
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Minnesota living with heart failure (MLHF) questionnaire baseline scores?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "significantly decreased" ]
121
374
3580134
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Sleep score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
122
319
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Peak expiratory flow in the morning and evening ?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
123
440
2600646
Compared to dihydroartemisinin-piperaquine (AP) what was the result of arthemeter-lumefantrine (AL) on mean Hb?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Final mean Hb levels were 7.15 mmol/l ± 1.07 for the DP treatment group and 6.79 mmol/l ± 1.24 for the AL group. A possible influence of anaemia on gametocyte carriage at enrollment was not observed in the present study (p > 0.05).
[ "no significant difference" ]
124
268
2691927
Compared to Conventional open approach what was the result of Laparoscopic surgery on Need for opiates?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
[ "significantly decreased" ]
125
241
3090298
Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Higher-order aberrations during the study?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
[ "no significant difference" ]
126
216
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Heart failure-related quality of life at the end of treatment?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "no significant difference" ]
127
326
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Baseline-adjusted average 12-hour FEV1 at end of treatment?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
128
443
1468428
Compared to no enema what was the result of 1 litre saline enema on Puerperal and neonatal infection rates ?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
We found no significant differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v 40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66)
[ "no significant difference" ]
129
341
3580134
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on 1-hour post-dose inspiratory capacity mean improvements from baseline to the average over the randomized treatment period?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
130
403
2690844
Compared to Midline incision what was the result of Transverse incision on Infection of the surgical site?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "no significant difference" ]
131
347
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Amount of exacerbations per patient-treatment year?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly decreased" ]
132
231
3090298
Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Uncorrected distance visual acuity at 1 month?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
[ "significantly decreased" ]
133
389
2690844
Compared to Midline incision what was the result of Transverse incision on Smaller incision ?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "significantly increased" ]
134
482
2899760
Compared to anterior cervical decompression and fusion (ACDF) with Trabecular MetalTM (TM) what was the result of raditional Smith–Robinson (SR) procedure with autograft on clinical outcomes?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
usion rate in the SR group was 92%, and in the TM group 69% (P < 0.05).
[ "no significant difference" ]
135
367
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Overall use of daily rescue medication improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
136
402
2690844
Compared to Midline incision what was the result of Transverse incision on Urinary retention?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "no significant difference" ]
137
283
2361806
Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Overall survival?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818).
[ "no significant difference" ]
138
397
2690844
Compared to Midline incision what was the result of Transverse incision on Procedure performed directly by the staff surgeon?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "no significant difference" ]
139
233
3090298
Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Corrected distance visual acuity at 6 months?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
[ "no significant difference" ]
140
254
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Patients infected with T. vaginalis?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "no significant difference" ]
141
282
2361806
Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Time to treatment failure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818).
[ "no significant difference" ]
142
385
2721929
Compared to Bladder training only (BT) what was the result of Bladder training plus tolterodine (Co) on Urgency score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each).
[ "significantly increased" ]
143
467
3387601
Compared to intravenous immunoglobulin (IVIG) what was the result of plasma exchange (PE) on negative correlation between CSF protein and duration of mechanical ventilation?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Examining the treatment groups separately, the significant negative correlation remained for the PE group (p-value = 0.037) and not for the IVIG group (p-value 0.132)
[ "significantly increased" ]
144
273
2691927
Compared to Conventional open approach what was the result of Laparoscopic surgery on Time to nasogastric decompression?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
[ "no significant difference" ]
145
456
3446002
Compared to control group what was the result of single dose of 50 mg/kg clofibrate on side effects?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed. Also for a period of two months no complication was detected.
[ "no significant difference" ]
146
269
2691927
Compared to Conventional open approach what was the result of Laparoscopic surgery on Hospital permanence?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
[ "no significant difference" ]
147
463
1876597
Compared to artemether-lumefantrine what was the result of dihydroartemisinin-piperaquine on Adverse Events?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Overall, there was no difference in the proportion of study participants who experienced any adverse event of moderate or greater severity between the DP (46%) and AL (42%) treatment groups (p = 0.47).
[ "no significant difference" ]
148
238
3090298
Compared to Pre-surgery baseline what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity at 3 months seen at 3 cpd?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
[ "no significant difference" ]
149
265
2691927
Compared to Conventional open approach what was the result of Laparoscopic surgery on Visual analog scale pain score at day 3?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
[ "significantly decreased" ]
150
395
2690844
Compared to Midline incision what was the result of Transverse incision on Average patient's weight?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "no significant difference" ]
151
264
2691927
Compared to Conventional open approach what was the result of Laparoscopic surgery on Visual analog scale pain score at day 1?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
[ "significantly decreased" ]
152
370
3580134
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Cough score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
153
479
2447617
Compared to placebo what was the result of progesterone on The analysis using the dichotomization of GOS scores at 3 months post injury?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048).
[ "significantly increased" ]
154
261
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Programme meeting attendance?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "significantly increased" ]
155
387
2721929
Compared to Tolterodine only (To) what was the result of Bladder training plus tolterodine (Co) on Urgency score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each).
[ "no significant difference" ]
156
237
3090298
Compared to Pre-surgery baseline what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity at 1 month seen at 3 cpd?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
[ "significantly decreased" ]
157
423
1187893
Compared to No exercise what was the result of Exercise on Knee injury and Osteoarthritis Outcome Score quality of life subscale at 6 months?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02).
[ "significantly increased" ]
158
323
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Mean FEV1 at 12 hours on the day of randomization?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
159
316
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on 1-hour post-dose FEV1 improvements?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
160
217
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline hypertension?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "no significant difference" ]
161
258
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Intake of STI treatment?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "no significant difference" ]
162
441
2600646
Compared to dihydroartemisinin-piperaquine (AP) what was the result of arthemeter-lumefantrine (AL) on Adverse events?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Final mean Hb levels were 7.15 mmol/l ± 1.07 for the DP treatment group and 6.79 mmol/l ± 1.24 for the AL group. A possible influence of anaemia on gametocyte carriage at enrollment was not observed in the present study (p > 0.05).
[ "no significant difference" ]
163
377
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on 24-hour urinary cortisol at 6 months?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly decreased" ]
164
218
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline diabetes?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "no significant difference" ]
165
255
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Secondary school education?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "no significant difference" ]
166
393
2690844
Compared to Midline incision what was the result of Transverse incision on Pain on day three after surgery?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "significantly decreased" ]
167
473
2847809
Compared to Placebo what was the result of Clopidogrel on First hemodialysis success?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03).
[ "significantly increased" ]
168
228
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline life-quality score?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "no significant difference" ]
169
401
2690844
Compared to Midline incision what was the result of Transverse incision on Cardiac complications?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "no significant difference" ]
170
310
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Time to discontinuation?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
171
355
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Breathlessness Cough and Sputum Scale improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
172
427
1187893
Compared to No exercise what was the result of Exercise on Functional performance improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02).
[ "no significant difference" ]
173
391
2690844
Compared to Midline incision what was the result of Transverse incision on Pain on day one after surgery?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "significantly decreased" ]
174
384
2721929
Compared to Bladder training only (BT) what was the result of Tolterodine only (To) on Urgency score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each).
[ "significantly increased" ]
175
259
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Self-reported STI symptoms?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "no significant difference" ]
176
407
2690844
Compared to Midline incision what was the result of Transverse incision on Better cosmetic appearance of the incision as subjectively assessed by patients?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
[ "significantly increased" ]
177
226
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Knowledge about heart failure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "significantly increased" ]
178
368
3580134
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Dyspnoea score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
179
257
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Genital discharge history?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "no significant difference" ]
180
220
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline beta-blockers intake?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "no significant difference" ]
181
369
3580134
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Breathlessness Cough and Sputum Scale improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
182
250
2922723
Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Visual analogue scale scores for efficacy?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
[ "significantly decreased" ]
183
450
2720945
Compared to placebo what was the result of cineole on Side effects?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups.
[ "no significant difference" ]
184
232
3090298
Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Corrected distance visual acuity at 1 month?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
[ "significantly decreased" ]
185
227
1475568
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Self-efficacy?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
[ "significantly increased" ]
186
477
2447617
Compared to placebo what was the result of progesterone on The mean intracranial pressure values 72 hours and 7 days after injury?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048).
[ "no significant difference" ]
187
281
2361806
Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Overall response rates?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818).
[ "significantly increased" ]
188
266
2691927
Compared to Conventional open approach what was the result of Laparoscopic surgery on Visual analog scale pain score at day 7?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
[ "significantly decreased" ]
189
380
3580134
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Incidence of pneumonia?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "no significant difference" ]
190
256
1831737
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Spatial mobility?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
[ "no significant difference" ]
191
285
2361806
Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Grade 3/4 digestive system toxic events?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818).
[ "significantly increased" ]
192
361
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Dyspnoea score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
193
365
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Sleep score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
194
461
1876597
Compared to artemether-lumefantrine what was the result of dihydroartemisinin-piperaquine on unadjusted risk of recurrent falciparum parasitemia?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Overall, there was no difference in the proportion of study participants who experienced any adverse event of moderate or greater severity between the DP (46%) and AL (42%) treatment groups (p = 0.47).
[ "significantly decreased" ]
195
328
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Baseline-adjusted average 12-hour FEV1 on the day of randomization?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
196
386
2721929
Compared to Tolterodine only (To) what was the result of Bladder training plus tolterodine (Co) on Micturition frequency?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each).
[ "no significant difference" ]
197
363
3580134
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Cough score improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
[ "significantly increased" ]
198
452
2720945
Compared to placebo what was the result of cineole on Mean of sum of number, duration and severity of exacerbations during 6 months of treatment?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups.
[ "significantly decreased" ]
199
455
3446002
Compared to control group what was the result of single dose of 50 mg/kg clofibrate on The duration of phototherapy?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed. Also for a period of two months no complication was detected.
[ "significantly decreased" ]